Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist

Area of Science:

• Hematology
• Immunology
• Infectious Diseases

Background:

• Coronavirus disease 19 (COVID-19) is a multisystemic illness.
• Persistent symptoms and late-onset complications, including hematological disorders, are reported post-COVID-19.
• COVID-19-induced coagulopathy, an immunothrombotic state, is associated with thromboembolic and hemorrhagic events.

Purpose of the Study:

• To review available evidence on post-acute COVID-19 hematological complications.
• To highlight the role of hematologists in managing long COVID-19.
• To emphasize the importance of laboratory monitoring for timely intervention.

Main Methods:

• Literature review of studies on post-COVID-19 hematological complications.
• Synthesis of evidence on COVID-19-induced coagulopathy and thrombocytopenia.
• Discussion of the multidisciplinary approach in long COVID-19 management.

Main Results:

• Post-COVID-19 hematological disorders are a significant concern.
• Late-onset thrombocytopenia, linked to immune dysregulation, is a rare manifestation.
• Close laboratory monitoring is crucial for identifying and managing hematological abnormalities.

Conclusions:

• Hematological complications are an important aspect of long COVID-19.
• Hematologists are essential in the multidisciplinary care of patients with post-COVID-19 hematological issues.
• Timely laboratory assessment and supportive care are vital for managing these conditions.